2019
DOI: 10.1177/1535370219829759
|View full text |Cite
|
Sign up to set email alerts
|

Precision prevention: A focused response to shifting paradigms in healthcare

Abstract: Human health and disease are defined at the intersection of molecules, environment, and lifestyle, which combined determine phenotypic outcomes. To date, most clinical applications in the precision medicine space have focused on DNA, with lesser attention given to the biology encoded by RNA molecules, or the complexity of biological regulation at the level of proteins and metabolites. The totality of this information must be integrated in ways that allow for implementation of knowledge-based health promotion a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Active LINEs are a source of endogenous mutagenesis, with reactivation in somatic cells causing a variety of genetic alterations, including aberrant splicing, exon skipping, gene fusions, and genome rearrangements that alter gene expression and cause genome instability [8][9][10]. Furthermore, LINE-1 reactivation creates a positive feedback loop that perpetuates the aberrant behavior of cells carrying mutations in tumor suppressor genes and/or oncogenes [11]. LINE-1 oncogenicity can also involve signaling pathways that are independent of retrotransposition [12].…”
Section: Introductionmentioning
confidence: 99%
“…Active LINEs are a source of endogenous mutagenesis, with reactivation in somatic cells causing a variety of genetic alterations, including aberrant splicing, exon skipping, gene fusions, and genome rearrangements that alter gene expression and cause genome instability [8][9][10]. Furthermore, LINE-1 reactivation creates a positive feedback loop that perpetuates the aberrant behavior of cells carrying mutations in tumor suppressor genes and/or oncogenes [11]. LINE-1 oncogenicity can also involve signaling pathways that are independent of retrotransposition [12].…”
Section: Introductionmentioning
confidence: 99%